Molnex (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride Trihydrate, the active ingredient in Molnex, is an opioid analgesic presented as a sterile injectable solution for epidural, intramuscular and intrathecal use. It is employed to manage severe acute pain, post‑operative pain, cancer‑related pain and chronic pain that requires opioid therapy.

GNH USA supplies Molnex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and clinics worldwide.

Molnex, an opioid analgesic, is used in conditions that involve intense nociceptive pain.

Severe acute pain: provides rapid relief of intense pain episodes. Post‑operative pain: helps control pain after surgical procedures. Cancer pain: manages persistent pain associated with malignant disease. Chronic pain requiring opioid therapy: offers long‑term analgesia when other treatments are insufficient.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea and vomiting - Constipation - Drowsiness or sedation - Itching or pruritus

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Anaphylactic or severe allergic reaction - Dependence, tolerance or addiction - Seizures

Careful assessment and monitoring are essential when using opioid analgesics.

Assess pain level: determine appropriate indication and dosage. Evaluate respiratory function: monitor for depression, especially after initiation. Monitor for signs of dependence: watch for misuse or addiction behaviors. Adjust dose in renal/hepatic impairment: reduce dosage or increase interval as needed. Use with caution in elderly patients: start with lower doses and titrate slowly. Store at controlled room temperature: keep in original container, protect from moisture and light.

Opioid therapy can be affected by several concomitant medications.

Major Interactions (Avoid): - Central nervous system depressants (e.g., benzodiazepines, barbiturates) - Monoamine oxidase inhibitors (MAOIs) - Other opioid analgesics - Alcohol consumption - Respiratory depressants (e.g., anesthetic gases)

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) - CYP3A4 inducers (e.g., rifampin, carbamazepine) - Diuretics (may enhance hypotensive effect)